https://www.selleckchem.com/pr....oducts/1-methyl-3-ni
Four independent datasets, including qRT-PCR and The Cancer Genome Atlas (TCGA), demonstrated that they can also be used to accurately predict the overall survival of CRC patients. Further analysis suggested that high-risk patients were characterized by worse effects of chemotherapy and immunotherapy, as well as lower immune scores. Ultimately, the signature was identified as an independent prognostic factor. The signature can accurately predict recurrence and overall survival in patients with CRC and may ser
Like
Comment
Share
